EverHint – SMA 20/50 Crossover, EMA 10 + Price + MACD, EMA 10/30 Crossover – Top 11 Buy and Top 7 Sell Signals for Nov 16, 2026
Excerpt: 18 signals (from 50 total). Healthcare leads (10). price range $8-$195. 3 with insider selling.
SMA 20/50 Crossover
Detects fresh crossovers between the 20-day simple moving average (SMA20) and the 50-day simple moving average (SMA50). Uses two SMAs, making it more stable and less prone to false signals compared to EMA-based strategies. Well-suited for identifying medium-term trend changes with higher reliability.
Entry Criteria:
- Buy: SMA20 crosses above SMA50
- Sell: SMA20 crosses below SMA50
- Minimum ADV: $40M (liquidity filter)
- Earnings buffer: 7 days pre/post earnings
- Fresh crossover: Detected on today's close
Holding period: 2-6 weeks | Risk level: Medium
🔴 Sell Signals (2 of 2)
| # | Ticker | Company | Sector | Price | Insider | MCap |
|---|---|---|---|---|---|---|
| 1 | DHT | DHT Holdings, Inc. | Industrials | $21.49 | — | $3.5B |
| 2 | LOGI | Logitech International... | Technology | $99.03 | — | $14.0B |
EMA 10 + Price + MACD
Experimental strategy combining price crossing above EMA10 from below with MACD Line crossing above Signal Line from below. Both conditions must occur on the same day for a signal, providing double confirmation and higher-quality setups.
Entry Criteria:
- Buy: Price > EMA10 AND MACD line crosses above signal line
- Sell: Price < EMA10 AND MACD line crosses below signal line
- Minimum ADV: $40M (liquidity filter)
- Earnings buffer: 7 days pre/post earnings
- Fresh signal: All conditions met on today's close
Holding period: 1-3 weeks | Risk level: Medium-High
🟢 Buy Signals (4 of 4)
Ranked by RSI (lower RSI = more oversold for buy signals)
| # | Ticker | Company | Sector | Price | Insider | MCap |
|---|---|---|---|---|---|---|
| 1 | INVH | Invitation Homes Inc. | Real Estate | $27.10 | — | $15.7B |
| 2 | POWL | Powell Industries, Inc. | Industrials | $151.20 | — | $5.5B |
| 3 | STNE | StoneCo Ltd. | Technology | $8.01 | Sell -$10,860 | $1.8B |
| 4 | TU | TELUS Corporation | Communication Services | $9.57 | — | $15.2B |
Insider selling (7d): STNE (-$10,860)
EMA 10/30 Crossover
Detects fresh crossovers between the 10-day exponential moving average (EMA10) and the 30-day exponential moving average (EMA30), generating both buy and sell signals. Uses two EMAs instead of EMA + SMA, making it more responsive to price changes and better suited for capturing short-to-medium term momentum shifts.
Entry Criteria:
- Buy: EMA10 crosses above EMA30
- Sell: EMA10 crosses below EMA30
- Minimum ADV: $40M (liquidity filter)
- Earnings buffer: 7 days pre/post earnings
- Fresh crossover: Detected on today's close
Holding period: 1-4 weeks | Risk level: Medium
🟢 Buy Signals (7 of 7)
Ranked by RSI (lower RSI for buy signals = more oversold)
| # | Ticker | Company | Sector | Price | Insider | MCap |
|---|---|---|---|---|---|---|
| 1 | CZR | Caesars Entertainment,... | Consumer Cyclical | $29.37 | — | $6.0B |
| 2 | EXPD | Expeditors Internation... | Industrials | $195.34 | — | $25.2B |
| 3 | MSGE | Madison Square Garden ... | Communication Services | $79.91 | — | $3.8B |
| 4 | PCG | PG&E Corporation | Utilities | $13.68 | — | $36.7B |
| 5 | PPC | Pilgrim's Pride Corpor... | Consumer Defensive | $29.11 | — | $6.9B |
| 6 | SFD | Smithfield Foods, Inc. | Consumer Defensive | $19.26 | — | $7.6B |
| 7 | SKM | SK Telecom Co.,Ltd | Communication Services | $33.32 | — | $12.8B |
🔴 Sell Signals (5 of 37)
| # | Ticker | Company | Sector | Price | Insider | MCap |
|---|---|---|---|---|---|---|
| 1 | AMCR | Amcor plc | Consumer Cyclical | $43.77 | — | $20.2B |
| 2 | ATI | ATI Inc. | Industrials | $173.28 | — | $23.5B |
| 3 | ATRC | AtriCure, Inc. | Healthcare | $55.31 | — | $2.8B |
| 4 | BANC | Banc of California, Inc. | Financial Services | $17.66 | — | $2.8B |
| 5 | BLLN | BillionToOne, Inc. | Healthcare | $96.31 | — | $4.6B |
Recent Headlines
POWL (Powell Industries, Inc.)
- Powell Industries Announces Fourth Quarter and Full Year Fiscal 2026 Results
Independent, data-driven signals.
No hype. No promotions. Just experimental market research from EverHint.
This is not financial advice. Market conditions change rapidly.
Do your own due diligence.
See https://www.everhint.com/disclaimer/ and https://www.everhint.com/faqs/
📢 Enjoying the updates? Liking, sharing, or subscribing helps bring this analysis to a wider audience.